Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Yant

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2020
Simulating HIV Breakthrough and Resistance Development During Variable Adherence to Antiretroviral TreatmentAndrew Mulato, Rima Acosta, Silvia Chang, et al.
Nature Biotechnology|September 24, 2002
Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivoStephen R Yant, Anja Ehrhardt, Jacob Giehm Mikkelsen, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2022
Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence <i>In Vitro</i>Rima K Acosta, Michelle L D'Antoni, Andrew Mulato, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Somatic integration from an adenoviral hybrid vector into a hot spot in mouse liver results in persistent transgene expression levels in vivoAnja Ehrhardt, Stephen R Yant, Jeffery C Giering, et al.
The Journal of Clinical Investigation|June 29, 2023
Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque modelElena Bekerman, Stephen R Yant, Laurie VanderVeen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2016
Structural Determinants of Sleeping Beauty Transposase ActivityGyörgy Abrusán, Stephen R Yant, András Szilágyi, et al.
AIDS Research and Human Retroviruses|July 1, 2016
Rapid In Vitro Evaluation of Antiretroviral Barrier to Resistance at Therapeutic Drug LevelsAndrew Mulato, Derek Hansen, Alex Thielen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8Bassel Akache, Dirk Grimm, Xuan Shen, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2015
Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease InhibitorsGabriel Birkus, Rujuta A Bam, Madeleine Willkom, et al.
Elife|December 18, 2014
Quantitative microscopy of functional HIV post-entry complexes reveals association of replication with the viral capsidKe Peng, Walter Muranyi, Bärbel Glass, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2020
Simulating HIV Breakthrough and Resistance Development During Variable Adherence to Antiretroviral TreatmentAndrew Mulato, Rima Acosta, Silvia Chang, et al.
Nature Biotechnology|September 24, 2002
Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivoStephen R Yant, Anja Ehrhardt, Jacob Giehm Mikkelsen, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2022
Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence <i>In Vitro</i>Rima K Acosta, Michelle L D'Antoni, Andrew Mulato, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Somatic integration from an adenoviral hybrid vector into a hot spot in mouse liver results in persistent transgene expression levels in vivoAnja Ehrhardt, Stephen R Yant, Jeffery C Giering, et al.
The Journal of Clinical Investigation|June 29, 2023
Long-acting lenacapavir acts as an effective preexposure prophylaxis in a rectal SHIV challenge macaque modelElena Bekerman, Stephen R Yant, Laurie VanderVeen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2016
Structural Determinants of Sleeping Beauty Transposase ActivityGyörgy Abrusán, Stephen R Yant, András Szilágyi, et al.
AIDS Research and Human Retroviruses|July 1, 2016
Rapid In Vitro Evaluation of Antiretroviral Barrier to Resistance at Therapeutic Drug LevelsAndrew Mulato, Derek Hansen, Alex Thielen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8Bassel Akache, Dirk Grimm, Xuan Shen, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2015
Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease InhibitorsGabriel Birkus, Rujuta A Bam, Madeleine Willkom, et al.
Elife|December 18, 2014
Quantitative microscopy of functional HIV post-entry complexes reveals association of replication with the viral capsidKe Peng, Walter Muranyi, Bärbel Glass, et al.
Pageof 4